Human medicines European public assessment report (EPAR): Pandemic Influenza Vaccine H5N1 Baxter AG, pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 16/10/2009, Revision: 8, Status: Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.